Dr. Cohen is President of the Hepatitis B Foundation, leading national and international efforts to eliminate hepatitis B through developing partnerships, capacity and strategies to improve hepatitis B and D screening, vaccination, and linkage to care.
Conflict of Interest: Receives consulting fees (all paid directly to the Hepatitis B Foundation. She represents the Hepatitis B Foundation on community advisory boards for Gilead Sciences, Roche, Arbutus, and GSK. Also, Hepatitis B Foundation receives research and program grants from Gilead Sciences, Genentech, GSK, VBI Vaccines, and Dynavax Technologies.